Heikki Lanckriet, CEO & CSO, 4Basebio |
Amy Walker, VP of Research & Business Development, 4Basebio |
Lykke Pedersen, Chief Pharma Officer, Abzu Aps |
Eszter Békefi, Proposal Manager, AGC Biologics |
Nate Spangler, CEO, Aldevron |
Michelle Werner, CEO & Director, Alltrna |
Vasant Jadhav, SVP, Head of RNAi Platform, Alnylam |
Clara Assouline, Director, Business Development, Anima Biotech |
Nicholas Marsh, Life Science Researcher, Arrakis Therapeutics |
Frederic Legros, Executive Chairman & CEO, ARTHEx Biotech |
Daniel Rosan, CEO, Ascidian Therapeutics |
Annette Bak, Senior Director - Head of Advanced Drug Delivery, AstraZeneca |
Sheri Ambriz, Senior Director - BD & Technical Solutio, Asymchem Inc |
Vishal Doshi, Chairman, AUM Biosciences |
Ariel Weinberger, CEO, Autonomous Therapeutics |
Mike Flanagan, Co-Founder & CEO, Avidity Biosciences |
Luis Brito, VP Delivery Platform, Beam Therapeutics |
Yannick Fillon, Head of Oligonucleotide Process Chemistry, Biogen |
Mark DeMario, CEO, BioNTech |
Andreas Kuhn, SVP RNA Biochemistry & CMC Development, BioNTech |
Gabriel Helmlinger, Associate Director, Scientific Strategy & Innovation, BIORCHESTRA |
Josh Mandel-Brehm, CEO, Camp4 Therapeutics Corporation |
Michael Rosenzweig, EVP, Capstan Therapeutics |
Christopher Jewell, CSO, Cartesian Therapeutics |
June Kim, Head of Targeted mRNA Delivery, CEPI (Coalition for Epidemic Preparedness and Innovation) |
Javier Gimenez, Director, Certest Pharma |
Shanthi Ganesh, Director, Discovery Research, Dicerna Pharmaceuticals |
Iris Grossman, Principal, Eleven Therapeutics |
Christalyn Rhodes, Associate VP- Genetic Medicine, External Partnerships & Collaborations, Eli Lilly |
Malgorzata Gonciarz, CEO & Co-Founder, Eli Lilly |
Tim Luker, VP Ventures, Eli Lilly |
Akihiro Ko, CEO, Elixirgen Therapeutics |
Dillon Flood, Co-Founder, Elsie Biotechnologies |
Ryan Cross, Senior Science Correspondent, Endpoints News |
Scott Laneman, Director of Innovation, Entegris |
Leo Qian, Co-Founder & VP, Discovery Research, Entrada Therapeutics |
Carsten Rudolph, CEO, Ethris |
Patrick Thiaville, CTO, Exothera |
Alex Philippidis, Senior Business Editor, Genetic Engineering & Biotechnology News |
Kathleen Kean, Partner, Goodwin Procter |
Matthew Hawryluk, Director of Product Management, Gritstone bio |
Andrew Ferguson, VP Clinical Development, Gritstone bio |
Leslie Williams, Co-Founder, Director, President & CEO, hC Bioscience |
Nick Davis, mRNA Senior Scientist, HOVANA |
David Slack, Senior Scientist, Impilo Therapeutics |
Derek Hicks, CBO, Intellia Therapeutics |
Eric Swayze, EVP, Research, Ionis Pharmaceuticals |
Tamar Grossman, VP, Global Head of RNA, Gene Therapy & Delivery, Johnson & Johnson |
Ram Aiyar, CEO, Korro Bio |
Katerina Krumova, CFO, Laronde |
Amy Espeseth, Head of Technical Operations, Laronde |
Daniel Anderson, Professor, Massachusetts Institute of Technology |
Daniel Quevedo, Senior Manager - Strategy & Business Development, METiS Therapeutics |
Camden Cutright, Business Development Director, Micropore Technologies |
Nagy Habib, Associate Director, Co-Founder, Chief Marketing Officer & Head of R&D, MiNA Therapeutics |
Can Ozbal, CEO, Momentum Biotechnologies |
Karin Kleinhans, Partner, MRLV |
Jayesh Kulkarni, Business Developer Manager, NanoVation Therapeutics |
Uli Stilz, Head of Bio Innovation Hub, Novo Nordisk |
Mahesh Karande, VP Lilly Genetic Medicine, Omega Therapeutics |
Thomas Barnes, CEO, Orna Therapeutics |
Pallavi Lonkar, CTO, PepGen |
Jing Zhu, VP of Nucleic Acid & Viral Vector Technology, Recipharm |
Dominic Reynolds, SVP, Head of Drug Discovery, Remix Therapeutics |
Sridhar Narayan, VP, Revir Therapeutics |
Shraddha Sharma, Associate Director, Sanofi |
Pierre Cote, Senior Director Strategic Partnerships & Innovation Management, mRNA CoE, Sanofi |
Guillaume Pfefer, CEO & CSO, Senda Biosciences |
Miroslav Gasparek, Co-Founder & CEO, Sensible Biotechnologies |
Jimmy Weterings, VP of Research, Sirnaomics |
Anna Perdrix Rosell, Founder & Co-CEO, Sixfold Bioscience |
Huw Nash, Director, RNA Market Sectors Lead, Stoke Therapeutics |
Dee Datta, CEO & Co-Founder, Switch Therapeutics |
May Guo, Key Account Manager, Synthgene |
Pedro Serrano, Senior Director & Head of Ribonucleic Acid & Protein Modulation, Takeda Pharmaceuticals |
Matthias Hackl, CEO, TAmiRNA |
David Davidson, VP Translational Neurology, Tessera Therapeutics |
Angela Genge, Executive Director, Clinical Research Unit (CRU), The Montreal Neurological Institute |
John Boyce, Co-Founder, Managing Director, TigerGene |
Alicia Irurzun-Lafitte, Partner, UCB Ventures |
Alex Kerr, Director of mRNA Platform, Unchained Labs |
Aimee Edinger, Professor, University of California Irvine |
Cesar Lopez-Camacho, Group Leader, University of Oxford |
James Carroll, Managing Director, Wharton Alumni Angels |
Dave Madge, VP Discovery Services, WuXi AppTec |
Olivier Tytgat, Business Development Manager, Ziphius Vaccines |